See the DrugPatentWatch profile for cosentyx

Based on the information available, there is no evidence to suggest that it is unsafe to take Cosentyx (secukinumab) immediately after receiving a flu shot. However, it is always best to consult with a healthcare professional before combining any medications or vaccines.

Cosentyx is a prescription medication used to treat a number of conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. It is a type of drug called a monoclonal antibody, which works by targeting and blocking a specific protein in the body that is involved in inflammation.

The flu shot, on the other hand, is a vaccine that is given to protect against the flu. It works by exposing the body to a small amount of the virus, which triggers the immune system to produce antibodies that will protect against future infection.

While there is no specific information available about taking Cosentyx immediately after a flu shot, it is generally considered safe to receive vaccines while taking monoclonal antibody therapies like Cosentyx. However, it is important to note that the immune response to the vaccine may be reduced in people taking these types of medications.

It is always best to consult with a healthcare professional before receiving any vaccinations or starting any new medications. They will be able to provide personalized advice based on your individual health history and current medications.

In summary, based on the available information, there is no evidence to suggest that it is unsafe to take Cosentyx immediately after receiving a flu shot. However, it is always best to consult with a healthcare professional before combining any medications or vaccines.

Sources:

1. Cosentyx (secukinumab) [Prescribing Information]. (2021). Novartis Pharmaceuticals Corporation. <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>
2. Influenza Vaccine. (2021). Centers for Disease Control and Prevention. <https://www.cdc.gov/flu/index.htm>
3. Monoclonal Antibodies. (2021). American Cancer Society. <https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/immunotherapy/monoclonal-antibodies.html>
4. DrugPatentWatch. Cosentyx (secukinumab) Drug Profile. <https://www.drugpatentwatch.com/drugs/cosentyx>